Home › NDC Lookup › Ingredients › Dextromethorphan Hbr › 58552-0144-04
🧴image loading
(from DailyMed)

Childrens Giltuss Honey DM Cough Dextromethorphan HBr 15 mg/5mL Solution — NDC 58552-144-04 (Billing 58552-0144-04) · Product 58552-144

by Gil Pharmaceutical Corp · 1 BOTTLE in 1 CARTON (58552-144-04) / 118 mL in 1 BOTTLE

NDC 58552-144-04 (billing 58552-0144-04) is a package of Childrens Giltuss Honey DM Cough Dextromethorphan HBr 15 mg/5mL Solution from Gil Pharmaceutical Corp, marketed since Jun 2020 and currently FDA-listed. It is the main listing for product NDC 58552-144, its only package size.

NDC 58552-0144-04
🏷️ FDA NDC (as labeled) 58552-144-04 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 58552-144-04
Product NDC 58552-144
11-digit billing NDC 58552014404
NCPDP billing unit ML — per mL (volume)
RxCUI 1090496
UNII 9D2RTI9KYH
Application # M012
SPL Set ID a8c5027f-9701-fb07-e053-2a95a90a6029
Established class (EPC) Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Mechanism of action Sigma-1 Receptor Agonists; Uncompetitive NMDA Receptor Antagonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-06-22
Route ORAL
Dosage form SOLUTION
Substance DEXTROMETHORPHAN HYDROBROMIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43102030500940
GPI class Giltuss Honey DM Childrens
Quick answers for NDC 58552-144-04
  • GPI-14 (Medi-Span): 43102030500940
  • RxCUI (RxNorm): 1090496
  • 11-digit billing NDC: 58552014404
Why two NDCs? The FDA registers this code as 58552-144-04 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 58552-0144-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Uncompetitive N-methyl-D-aspartate Receptor Antagonist class.

Pharmacologic class Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Sigma-1 Agonist
Drug family (ATC) Other antidepressants, Opium alkaloids and derivatives
How it works Uncompetitive NMDA Receptor Antagonists, Sigma-1 Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It's a cough suppressant. It temporarily relieves cough from minor throat and bronchial irritation, like with a cold or inhaled irritants. Some products also help you sleep by calm...
  • It depends on the product. Extended-release suspensions like Delsym are labeled for every 12 hours, while Giltuss Honey DM Cough is every 6 to 8 hours with a 4-dose daily limit. Ch...
  • Be careful. Don't use it if you take a prescription MAOI, or within 2 weeks of stopping one. If you're not sure whether your medicine is an MAOI, ask me or your doctor before takin...
  • Nighttime products can cause marked drowsiness, and children may become excitable. Avoid alcohol and be careful driving.
📖 Read our full Dextromethorphan guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
58552-0144-04 58552-144-04 You're viewing this Main listing 1 BOTTLE in 1 CARTON (58552-144-04) / 118 mL in 1 BOTTLE 2020-06-22 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Long Acting Cough Adult Tussin 30 mg/10mL 46122-0784-29 AMERISOURCE 1 bottle $0.023 — Availability likely —
Adult Cough Relief 15 mg/5mL 83324-0134-04 QUALITY 1 bottle $0.023 — Availability likely —
Cough Relief Adult 15 mg/5mL 36800-0509-04 TOP 1 bottle — — FDA listed —
Tussin Long Acting Cough READYINCASE 30 mg/10mL 49580-0383-04 P 1 bottle — — Discontinued —
Cough Relief Adult 15 mg/5mL 55910-0309-04 Dolgencorp, 1 bottle — — FDA listed —
Giltuss Honey DM Cough 30 mg/10mL 58552-0143-04 Gil 1 bottle — — FDA listed —
Childrens Giltuss Honey DM Cough 15 mg/5mLthis 58552-0144-04 Gil 1 bottle — — FDA listed —
Giltuss Diabetic Dm 30 mg/10mL 58552-0149-04 Gil 1 bottle — — FDA listed —
Giltuss DM 30 mg/10mL 58552-0150-04 Gil 1 bottle — — FDA listed —
Mielim y mas 15 mg/5mL 58593-0295-04 Efficient 118 ml — — Discontinued —
Cough Relief Cough Suppressant 15 mg/5mL 63868-0957-04 QUALITY 1 bottle — — FDA listed —
Cough Relief 15 mg/5mL 63941-0309-04 Best 1 bottle — — FDA listed —
Cough Relief 15 mg/5mL 63941-0455-04 Best 1 bottle — — FDA listed —
Giltuss Honey DM Cough 30 mg/10mL 65852-0004-04 Dextrum 1 bottle — — FDA listed —
Childrens Giltuss Honey DM Cough 15 mg/5mL 65852-0007-04 Dextrum 1 bottle — — FDA listed —
Premier Value Tussin Cough Long Acting 30 mg/10mL 68016-0742-04 Chain 1 bottle — — FDA listed —
DRx Choice Long Acting Cough 30 mg/10mL 68163-0742-04 RARITAN 1 bottle — — FDA listed —
CVS Long Acting Cough 30 mg/10mL 69842-0634-04 CVS 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Jun 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGil Pharmaceutical Corp
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code58552
First marketedJun 2020
Product typeHuman Otc Drug
Portfolio31 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 34 words ▾

Uses temporarily relieves: cough due to minor throat and bronchial irritation associated with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help your child get to sleep

⏱️ Dosage and Administration 66 words ▾

Directions do not take more than 4 doses in any 24-hour period use enclosed dosing cup keep dosage cup for use with this product ml = milliliters children under 4 years Consult a doctor children 4 to under 6 years 2.5 mL every 6-8 hours children 6 to under 12 years 5 mL every 6-8 hours children 12 years and over 10 mL every 6-8 hours

⚠️ Warnings 144 words ▾

Warnings Do not use if your child is now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if the child has cough that occurs with too much phlegm (mucus) a persistent or chronic cough such as occurs with asthma Stop use and ask a doctor if the child has a cough that lasts for more than 7 days, comes back, or is accompanied by fever, rash or persistent headache.

These could be signs of a serious condition. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 17 words ▾

Other information store at room temperature 15°-30°C (59°-86°F) close cap tightly SAVE CARTON FOR COMPLETE DRUG FACTS

🧪 Active Ingredient 10 words ▾

Active ingredient (in each 5 mL) Dextromethorphan HBr, 15 mg

🧪 Inactive Ingredients 19 words ▾

Inactive ingredients natural and artificial flavor, natural grade A honey, methylparaben, potassium sorbate, propylene glycol, propylparaben, purified water, sucralose.

📄 Do Not Use 57 words ▾

Do not use if your child is now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 27 words ▾

Ask a doctor before use if the child has cough that occurs with too much phlegm (mucus) a persistent or chronic cough such as occurs with asthma

📄 Stop Use and Ask a Doctor If 38 words ▾

Stop use and ask a doctor if the child has a cough that lasts for more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. These could be signs of a serious condition.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 23 words ▾

Questions or comments? Call 1-787-848-9114 , Monday-Friday 9AM - 5PM EST. Call your doctor for medical advice in the event of side effects.

📄 Package Label / Principal Display Panel 34 words ▾

Children 4-12 Children's Giltuss® Honey DM Cough Alcohol Free. Dye Free. Non Drowsy. PERSISTENT COUGH UP TO 8 HOURS Made with real honey HONEY LEMON FLAVOR. 4FL OZ (118 mL) 58552-144 Honey DM Child

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Childrens Giltuss Honey DM Cough (this brand).

Top reported reactions

Drug Abuse109
Cardiac Arrest21
Completed Suicide21
Respiratory Arrest21
Death16
Toxicity To Various Agents12
Drug Hypersensitivity10

Age at onset

Adult3
Elderly1

Reporter sex

213 reports
Male · 57%
Female · 43%
Unknown · 0%

Serious outcomes

Hospitalization28
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 58552-144-04, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 58552-0144-04, written without dashes as 58552014404. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 58552-0144-04, the first segment (58552) is the labeler code FDA assigned to Gil Pharmaceutical Corp; the middle segment (0144) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (04) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Gil Pharmaceutical Corp. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Gil Pharmaceutical Corp is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 58552-0143-04 · Gil 58552-0145-04 · Gil →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.